Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer (beta)
Based on guidelines from AUA, ASCO, ASTRO, and SUO.
Strength
Strong recommendation
Moderate recommendation
Conditional recommendation
Evidence
Grade A quality evidence
Grade B quality evidence
Grade C quality evidence
Clinical principle
Expert opinion